Published in Cancer on July 15, 1999
European Low and Intermediate Risk Neuroblastoma Protocol | NCT01728155
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol (2008) 6.66
Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell (2012) 5.44
Copy number variation at 1q21.1 associated with neuroblastoma. Nature (2009) 4.10
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med (2008) 3.80
Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer (2013) 2.44
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol (2013) 2.25
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer (2009) 2.13
Computer-aided Prognosis of Neuroblastoma on Whole-slide Images: Classification of Stromal Development. Pattern Recognit (2009) 2.12
Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study. J Clin Oncol (2011) 1.79
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat Genet (2012) 1.74
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci U S A (2008) 1.59
Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol (2007) 1.59
Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci. PLoS Genet (2011) 1.57
Biological role of anaplastic lymphoma kinase in neuroblastoma. Am J Pathol (2005) 1.51
k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction. Pharmacogenomics J (2010) 1.46
Computerized pathological image analysis for neuroblastoma prognosis. AMIA Annu Symp Proc (2007) 1.43
Pax genes in embryogenesis and oncogenesis. J Cell Mol Med (2008) 1.37
Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res (2009) 1.29
Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma. Mol Cancer Ther (2009) 1.22
Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma. BMC Cancer (2010) 1.20
Presacral ganglioneuroma: a case report and review of literature. World J Gastroenterol (2007) 1.20
Advances in Risk Classification and Treatment Strategies for Neuroblastoma. J Clin Oncol (2015) 1.19
Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database. J Clin Oncol (2008) 1.18
Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol (2014) 1.17
Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model. Neoplasia (2011) 1.15
Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma. Dis Model Mech (2012) 1.14
HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma. Cancer Res (2011) 1.10
Novel use of a Weerda laryngoscope for transoral excision of a cervical ganglioneuroma: a case report. J Med Case Rep (2012) 1.09
MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am J Pathol (2009) 1.08
Novel epitheliomesenchymal biphasic stomach tumour (gastroblastoma) in a 9-year-old: morphological, ultrastructural and immunohistochemical findings. J Clin Pathol (2010) 1.08
Experience with International Neuroblastoma Staging System and Pathology Classification. Br J Cancer (2002) 1.06
CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. Neoplasia (2007) 1.05
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer (2008) 1.05
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors. Mol Cancer (2010) 1.03
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma. Mol Cancer (2010) 1.03
Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol (2001) 1.03
A three-gene expression signature model for risk stratification of patients with neuroblastoma. Clin Cancer Res (2012) 1.02
The connections between neural crest development and neuroblastoma. Curr Top Dev Biol (2011) 1.01
Mechanisms of CHD5 Inactivation in neuroblastomas. Clin Cancer Res (2012) 1.00
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG. Pediatr Blood Cancer (2009) 1.00
Clinical presentations and imaging findings of neuroblastoma beyond abdominal mass and a review of imaging algorithm. Br J Radiol (2011) 0.99
B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via β₁ integrin signaling in neuroblastoma. Am J Pathol (2011) 0.97
Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas. Am J Pathol (2001) 0.97
Ganglioneuroblastoma: Case report and review of the literature. J Ultrasound (2011) 0.96
DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis. PLoS One (2012) 0.95
Gene profiling of high risk neuroblastoma. World J Surg (2005) 0.94
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group. Pediatr Blood Cancer (2009) 0.94
In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients' shorter overall survival. Eur Spine J (2015) 0.93
Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. Br J Cancer (2000) 0.93
Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts. Am J Pathol (2005) 0.92
Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma. Am J Pathol (2001) 0.92
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee. Pediatr Blood Cancer (2012) 0.91
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma. BMC Cancer (2009) 0.91
Content-based microscopic image retrieval system for multi-image queries. IEEE Trans Inf Technol Biomed (2012) 0.91
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol (2003) 0.91
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system. Mol Oncol (2014) 0.90
Ultra-High Density SNParray in Neuroblastoma Molecular Diagnostics. Front Oncol (2014) 0.90
Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas. Proc Natl Acad Sci U S A (2013) 0.90
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma. Oncotarget (2014) 0.89
Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience. J Pediatr Surg (2010) 0.89
Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors. Oncogene (2015) 0.89
Ganglioneuroblastoma of the posterior mediastinum: a case report. J Med Case Rep (2011) 0.88
Computer-aided evaluation of neuroblastoma on whole-slide histology images: Classifying grade of neuroblastic differentiation. Pattern Recognit (2009) 0.87
2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics. Am J Pathol (2010) 0.87
Two independent epigenetic biomarkers predict survival in neuroblastoma. Clin Epigenetics (2015) 0.86
Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn. Oncogene (2012) 0.86
Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma. Neuro Oncol (2008) 0.86
Evaluation of genes identified by microarray analysis in favorable neuroblastoma. Pediatr Surg Int (2009) 0.86
Energy metabolism in neuroblastoma and Wilms tumor. Transl Pediatr (2015) 0.86
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group. Pediatr Dev Pathol (2014) 0.86
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform. Neoplasia (2012) 0.85
GLUT1 protein expression correlates with unfavourable histologic category and high risk in patients with neuroblastic tumours. Virchows Arch (2013) 0.85
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study. Br J Cancer (2015) 0.84
IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma. PLoS One (2012) 0.84
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database. J Clin Oncol (2014) 0.84
A 6-gene signature identifies four molecular subgroups of neuroblastoma. Cancer Cell Int (2011) 0.84
Expression and significance of HER family receptors in neuroblastic tumors. Clin Exp Metastasis (2011) 0.84
Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data. Diagn Pathol (2013) 0.84
Clinical significance of NTRK family gene expression in neuroblastomas. Pediatr Blood Cancer (2011) 0.83
Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication. BMC Cancer (2010) 0.83
Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases. Virchows Arch (2003) 0.83
Presacral ganglioneuroma: diagnostic considerations and therapeutic strategy. Case Rep Oncol (2013) 0.83
High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology. Eur J Nucl Med Mol Imaging (2013) 0.82
Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer. PLoS One (2013) 0.82
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age. J Clin Oncol (2011) 0.82
Reconstitution of Schwannian stroma in neuroblastomas using human bone marrow stromal cells. Am J Pathol (2008) 0.82
Intratumoral diversity of telomere length in individual neuroblastoma tumors. Oncotarget (2015) 0.82
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer (2015) 0.82
Neuroblastoma originating from extra-abdominal sites: association with favorable clinical and biological features. J Korean Med Sci (2009) 0.81
Primary congenital sacrococcygeal neuroblastoma: A case report with immunohistochemical study and review of literature. J Pediatr Neurosci (2013) 0.81
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors. Cell Death Dis (2014) 0.81
2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells. Cancer Biol Ther (2010) 0.81
Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma. Oncoimmunology (2015) 0.81
GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma. Oncotarget (2014) 0.81
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma. Cochrane Database Syst Rev (2015) 0.80
LYVE-1 upregulation and lymphatic invasion correlate with adverse prognostic factors and lymph node metastasis in neuroblastoma. Virchows Arch (2012) 0.80
An epidural neuroblastoma causing spinal cord compression in a 67-year-old woman. Rare Tumors (2010) 0.80
High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma. PLoS One (2013) 0.80
Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome. Transl Oncol (2009) 0.80
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17
Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol (1995) 11.26
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med (1999) 9.02
Molecular biology of neuroblastoma. J Clin Oncol (1999) 6.54
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30
Effects of inhalable particles on respiratory health of children. Am Rev Respir Dis (1989) 4.49
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med (1998) 4.39
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol (1988) 4.35
Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer (2001) 3.77
Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene (1990) 3.74
Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology (2010) 3.35
Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst (1999) 3.35
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol (1999) 3.35
Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med (1993) 3.33
Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer (1999) 3.28
Effects of ambient sulfur oxides and suspended particles on respiratory health of preadolescent children. Am Rev Respir Dis (1986) 3.18
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1991) 3.16
Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol (1990) 3.01
Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol (1998) 2.98
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol (2005) 2.97
Pleuropulmonary blastoma: a clinicopathologic study of 50 cases. Cancer (1997) 2.87
Pleuropulmonary blastoma: a marker for familial disease. J Pediatr (1996) 2.83
Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol (2001) 2.80
Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis. Cancer (1979) 2.76
Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol (1998) 2.65
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Morphologic diversity in malignant melanomas. Am J Clin Pathol (1990) 2.39
Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med (1995) 2.38
False-positive interpretations of carcinoma in exfoliative respiratory cytology. Report of two cases and a review of underlying disorders. Am J Clin Pathol (1995) 2.34
Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood. Cancer (1988) 2.24
Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. Hum Pathol (1986) 2.23
Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood (1991) 2.22
Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study. Neurology (2011) 2.17
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer (2009) 2.13
Immune deficiency syndrome in children. JAMA (1983) 2.12
Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol (1990) 2.11
Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol (2001) 2.07
Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med (1996) 2.05
Pathologist or laboratory physician? Lancet (1995) 2.04
Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res (1990) 2.00
Adequacy of bone marrow trephine biopsy specimens in children. J Clin Pathol (1996) 1.97
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol (1996) 1.94
Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer (1997) 1.94
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol (1998) 1.88
Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Mod Pathol (1999) 1.88
Proteinuria and clinical outcomes after ischemic stroke. Neurology (2012) 1.84
Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption. J Pediatr Hematol Oncol (1999) 1.84
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene (1999) 1.79
The enigmatic inflammatory pseudotumours: the current state of our understanding, or misunderstanding. J Pathol (2000) 1.79
Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology (2000) 1.76
Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol (2000) 1.74
Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol (1985) 1.72
Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology (2011) 1.71
Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol (1995) 1.68
Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75. J Exp Med (1995) 1.67
Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res (1988) 1.67
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening. Lancet (1991) 1.65
Metastatic malignant melanoma with "rhabdoid" features. Am J Clin Pathol (1994) 1.65
Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res (1995) 1.64
Favorable vs unfavorable histologic appearance. The lexicon of pathologic grading of solid malignant neoplasms in children. Arch Pathol Lab Med (1992) 1.64
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer (1997) 1.63
Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol (1997) 1.62
Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol (1999) 1.61
Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases. Arch Pathol Lab Med (1993) 1.61
Malignant rhabdoid tumor of the vulva: is distinction from epithelioid sarcoma possible? A pathologic and immunohistochemical study. Am J Surg Pathol (1989) 1.61
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer (2001) 1.58
Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus. Arch Pathol Lab Med (1986) 1.58
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. Med Pediatr Oncol (2001) 1.58
Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol (2000) 1.54
The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma. J Clin Oncol (1991) 1.52
Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr (1996) 1.51
Development and validation of an ultrasonographic activity index of Crohn's disease. Eur J Gastroenterol Hepatol (1999) 1.51
Iron metabolism in copper-deficient swine. J Clin Invest (1968) 1.51
Altered spectrin dimer-dimer association and instability of erythrocyte membrane skeletons in hereditary pyropoikilocytosis. J Clin Invest (1981) 1.49
Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population. Neurology (2006) 1.49
A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry. Am J Obstet Gynecol (1989) 1.49
Fish glucocorticoid receptor with splicing variants in the DNA binding domain. FEBS Lett (1996) 1.47
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg (1991) 1.47
Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol (2002) 1.47